BACKGROUND: The human immunodeficiency virus (HIV) has resulted in epidemiological shifts with an emergence of tuberculosis (TB) amongst HIV-infected women and infants. There are limited data on the TB disease spectrum and outcome amongst HIV-infected infants. OBJECTIVES: We describe the clinical characteristics, treatment and survival of HIV-infected infants with culture-confirmed TB. METHODS: This retrospective hospital-based study from Cape Town, South Africa, used routine laboratory-based surveillance among infants diagnosed with culture-confirmed TB from 1 January 2004 to 31 December 2006. Folder and chest radiographic review were completed and vitality status established. TB was classified as pulmonary, extra-pulmonary or disseminated disease. RESULTS: Of 52 infants, 37 (71.1%) had pulmonary, 2 (3.9%) extra-pulmonary only, 7 (13.5%) pulmonary and extra-pulmonary and 6 (11.5%) disseminated TB. Forty-six (88.5%) were started anti-tuberculosis therapy; 37 (71.2%) received antiretroviral therapy (ART) and 17 (32.7%) died, 10 (19.2%) of whom never started ART. HIV stage 4 disease was associated with death. TB treatment outcome was poorly documented. CONCLUSIONS: TB is associated with advanced HIV disease and high mortality in HIV-infected infants. Missed opportunities for initiation of ART were frequent. Although the effects of young age, TB disease spectrum and HIV co-infection are difficult to distinguish, our findings support the initiation of early ART in HIV-infected infants with TB.
BACKGROUND: The human immunodeficiency virus (HIV) has resulted in epidemiological shifts with an emergence of tuberculosis (TB) amongst HIV-infectedwomen and infants. There are limited data on the TB disease spectrum and outcome amongst HIV-infectedinfants. OBJECTIVES: We describe the clinical characteristics, treatment and survival of HIV-infectedinfants with culture-confirmed TB. METHODS: This retrospective hospital-based study from Cape Town, South Africa, used routine laboratory-based surveillance among infants diagnosed with culture-confirmed TB from 1 January 2004 to 31 December 2006. Folder and chest radiographic review were completed and vitality status established. TB was classified as pulmonary, extra-pulmonary or disseminated disease. RESULTS: Of 52 infants, 37 (71.1%) had pulmonary, 2 (3.9%) extra-pulmonary only, 7 (13.5%) pulmonary and extra-pulmonary and 6 (11.5%) disseminated TB. Forty-six (88.5%) were started anti-tuberculosis therapy; 37 (71.2%) received antiretroviral therapy (ART) and 17 (32.7%) died, 10 (19.2%) of whom never started ART. HIV stage 4 disease was associated with death. TB treatment outcome was poorly documented. CONCLUSIONS: TB is associated with advanced HIV disease and high mortality in HIV-infectedinfants. Missed opportunities for initiation of ART were frequent. Although the effects of young age, TB disease spectrum and HIV co-infection are difficult to distinguish, our findings support the initiation of early ART in HIV-infectedinfants with TB.
Authors: Elisabetta Walters; Marieke Magrieta van der Zalm; Megan Palmer; Corné Bosch; Anne-Marie Demers; Heather Draper; Pierre Goussard; Hendrik Simon Schaaf; Sven Olaf Friedrich; Andrew Whitelaw; Robin Warren; Robert P Gie; Anneke C Hesseling Journal: Pediatr Infect Dis J Date: 2017-09 Impact factor: 2.129
Authors: A C Hesseling; S Kim; S Madhi; S Nachman; H S Schaaf; A Violari; T C Victor; G McSherry; C Mitchell; M F Cotton Journal: Int J Tuberc Lung Dis Date: 2012-02 Impact factor: 2.373
Authors: Helen E Jenkins; Courtney M Yuen; Carly A Rodriguez; Ruvandhi R Nathavitharana; Megan M McLaughlin; Peter Donald; Ben J Marais; Mercedes C Becerra Journal: Lancet Infect Dis Date: 2016-12-08 Impact factor: 25.071
Authors: Saeeda Bobat; Matthew Darby; Dunja Mrdjen; Charlotte Cook; Erin Logan; Jennifer Auret; Elizabeth Jones; Corinna Schnoeller; Adriana Flores-Langarica; Ewan A Ross; Alykhan Vira; Constantino López-Macías; Ian R Henderson; James Alexander; Frank Brombacher; William G Horsnell; Adam F Cunningham Journal: PLoS Negl Trop Dis Date: 2014-12-04
Authors: Sophie Desmonde; Anne M Neilan; Beverly Musick; Gabriela Patten; Kulkanya Chokephaibulkit; Andrew Edmonds; Stephany N Duda; Karen Malateste; Kara Wools-Kaloustian; Andrea L Ciaranello; Mary-Ann Davies; Valériane Leroy Journal: J Int AIDS Soc Date: 2020-10 Impact factor: 5.396
Authors: Anna M Mandalakas; Alexander W Kay; Jason M Bacha; Tara Devezin; Rachel Golin; Katherine R Simon; Dilsher Dhillon; Sandile Dlamini; Andrew DiNardo; Mogo Matshaba; Jill Sanders; Lineo Thahane; Pauline M Amuge; Saeed Ahmed; Moorine P Sekadde; Neway G Fida; Bhekumusa Lukhele; Nodumo Chidah; David Damba; Joseph Mhango; Moses Chodota; Makhorong Matsoso; Angelina Kayabu; Richard S Wanless; Gordon E Schutze Journal: Emerg Infect Dis Date: 2020-12 Impact factor: 6.883